High risk profile(s)-Not a high risk profile Posts on Medivizor
Navigation Menu

High risk profile(s)-Not a high risk profile Posts on Medivizor

Is accelerated partial breast irradiation as good as whole breast irradiation?

Is accelerated partial breast irradiation as good as whole breast irradiation?

Posted by on Oct 23, 2017 in Breast cancer | 0 comments

In a nutshell This study examined accelerated partial breast irradiation (APBI) in comparison to whole breast irradiation (WBI) after surgery. They concluded that survival and long-term side-effects are the same for both treatments. However, ABPI had a higher rate of local recurrence as compared to WBI. Some background For early stage breast...

Read More

Comparing axillary lymph node ultrasound and fine needle aspiration in breast cancer

Posted by on Mar 4, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether patients with a suspicious axillary lymph node (ALN) but negative fine-needle aspiration result (FNA) can be considered as having node-negative disease (AUN). The study concluded that patients with suspicious ALN on ultrasound but negative FNA results can be treated as having node-negative disease. Some...

Read More

Who should receive radiotherapy after breast-conserving surgery for ductal carcinoma in situ?

Who should receive radiotherapy after breast-conserving surgery for ductal carcinoma in situ?

Posted by on Feb 1, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the rate of loco-regional recurrence (LRR) when breast-conserving surgery (BSC) was not followed by radiotherapy. This study concluded that the rate of LRR was low in patients who did not undergo radiation after BCS, but that age and margin width were risk factors for LRR. Some background BCS is a surgery...

Read More

What is the preferred duration of chemotherapy? – A review of clinical trials

What is the preferred duration of chemotherapy? – A review of clinical trials

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

The aim of this paper was to identify if a longer course of chemotherapy was better than a short course. The authors look at how long patients survived with metastatic breast cancer or with no further cancer progression. Breast cancer is called metastatic when it has spread from the breast to other parts of the body such as the lymph nodes, lungs,...

Read More